ModifiedUnitedHealthcarePolicy MP.027.12

Enteral Nutrition (Oral and Tube Feeding)

Governs medical necessity and coverage for enteral nutrition provided orally or via tube for UnitedHealthcare Commercial and Individual Exchange plans; outlines clinical criteria, definitions, coding, and coverage limitations.

Policy Summary

PayerUnitedHealthcare

PolicyEnteral Nutrition (Oral and Tube Feeding)

Policy CodePolicy MP.027.12

Change TypeCoverage criteria revised — expanded qualifying conditions for oral Specialized Nutrient Formula

Effective DateJun 1, 2025

Next Review DateN/A

Key ActionObtain and document a prescriber order and clinical evidence that the condition is chronic and oral nutrition cannot meet needs; verify member plan and submit prior authorization per InterQual when tube feeding is requested.

SourceLink

POLICY UPDATE CHANGES

Revised coverage criteria for Specialized Nutrient Formula administered orally as a primary or supplementary source of nutrition to expand the list of qualifying conditions to include food protein‑induced allergic proctocolitis (FPIAP) and food protein‑induced enterocolitis syndrome (FPIES).

Updated indication label from 'Gastroesophageal reflux with failure to thrive' to 'gastroesophageal reflux with failure to thrive (in children)'.

Updated the definition of 'Medical Food'.

Updated Clinical Evidence and References sections to reflect current information.

Primary sourceInterQual referenced

5 requirementsOral criteria required

90.8%

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

EoE elemental efficacy

Standard formulaCommon exclusions

MultipleHCPCS/S codes listed

Coverage Criteria for Enteral Nutrition

Tube Feeding Medical Necessity (InterQual-referenced)

Enteral nutrition by tube feeding is medically necessary when InterQual Durable Medical Equipment (DME) — Enteral and Parenteral Nutrition Therapy criteria are met.

Tube feeding: Tube-enteral nutrition medical necessity determined per InterQual CP: Durable Medical Equipment; Enteral and Parenteral Nutrition Therapy

Refer to InterQual criteria for specific clinical triggers and documentation requirements

Oral Specialized Nutrient Formula — Medical Necessity

Oral Specialized Nutrient Formula (Medical Food) is considered medically necessary when ALL of the following are met:

Oral Medical Food criteria: 1) The condition is chronic and expected to last for an undetermined or prolonged period; 2) A physician, advanced practitioner (NP, CNS, or PA), or registered dietitian prescribes the therapy; 3) Adequate nutrition is not possible by dietary adjustment; 4) The individual has a qualifying condition (e.g., inborn errors of metabolism, CKD <24 months, severe food allergies/EoE per revised list); 5) The formula used is a Medical Food specially formulated for the specific condition.

All five requirements must be documented to consider oral specialized formula medically necessary.

Coverage criteria by condition

Covered when clinical indication is supported by guideline recommendations, randomized trials, or clear clinical need:

Inborn errors of metabolism (e.g., PKU, galactosemia): Initiation and continuation of low-phenylalanine diets and use of specialized medical foods (amino acid–based medical foods or glycomacropeptide medical foods) are medically indicated for diagnosed PKU and for infants with suspected classical galactosemia (galactose restriction); vitamin/mineral supplementation and nutrition monitoring are required when medical foods lack complete nutrients.

Evidence includes systematic reviews and randomized crossover trials showing biochemical and adherence outcomes.

Chronic kidney disease (pediatrics): Enteral nutrition (specialized renal formulas, increased energy and protein prescriptions) is indicated for children with CKD and growth deficits when oral intake is inadequate despite dietary counseling; protein and energy targets should follow KDOQI/PRNT and AAP guidance with monitoring of calcium and phosphate.

Recommendations from KDOQI/PRNT and AAP cited.

Crohn's disease: Exclusive enteral nutrition (EEN), partial enteral nutrition, and Crohn's Disease Exclusion Diet (CDED) are supported for induction and maintenance of remission in pediatric mild-to-moderate Crohn's disease; consider CDED plus partial enteral nutrition where evidence shows improved tolerance and sustained remission.

Guideline‑based indications and policy revisions

Coverage and medical necessity reference points and guideline‑based indicators used to support coverage determinations include:

Guideline support: Professional guidelines (Academy/ASPEN, ESPEN, NICE, NASPGHAN/ESPGHAN, AGA/Joint Task Force) inform indications and monitoring for oral and enteral nutrition support.

See referenced guideline excerpts for specifics.

Adult malnutrition diagnosis: Diagnosis is supported when TWO OR MORE of the following are present: unintentional weight loss; insufficient energy intake; loss of muscle mass; loss of subcutaneous fat; diminished functional status (e.g., hand grip strength); localized or generalized fluid accumulation.2+ characteristics

Academy/ASPEN consensus statement.

Pediatric malnutrition thresholds: Pediatric malnutrition should be assessed using standardized indicators (weight-for-height, BMI-for-age, length/height-for-age, circumference z-scores, weight gain velocity); severity defined by z-score cutoffs (eg severe <= -3 z).

Coverage excludes ordinary foods and non‑medical nutrition products. Specifically, food of any kind, infant formula, standard milk‑based formula, and donor breast milk are not covered under commercial plans. The policy also excludes self‑blenderized formulas for oral intake, commercial food thickeners, and other enteral additives or electrolyte fluids used for oral intake except when the coverage criteria for specialized medical foods or enteral nutrition are met. Refer to the member specific benefit document for plan‑level exclusions that may apply.

For phenylketonuria (PKU) and other inborn errors of metabolism, the evidence base does not establish precise thresholds for when dietary restrictions may be relaxed. Systematic reviews and randomized crossover trials show benefit from continuing low‑phenylalanine diets and that protein substitute dosing influences blood phenylalanine levels, but they conclude there is insufficient high‑quality evidence to define exact phenylalanine targets or specific timing for diet relaxation. Therefore, any relaxation of restrictive metabolic diets should be done cautiously and guided by metabolic specialists with objective monitoring of blood phenylalanine and other relevant biochemical markers.

Information about FDA regulatory status is provided for context only. FDA approval, clearance, or classification is informational and does not by itself determine coverage. Coverage decisions are made using the policy’s medical necessity criteria and must be reconciled with the member specific benefit plan and any applicable federal or state mandates; when a conflict exists, the member specific benefit plan governs.

Oral Specialized Nutrient Formula (medical foods) are considered not medically necessary when the oral coverage criteria are not fully met. Examples include use of specialized formulas in place of standard oral nutrition when there is no documentation that adequate nutrition cannot be achieved by dietary adjustment, or when the required prescriber order and evidence of a qualifying chronic condition are not provided.

FDA approval alone is not sufficient to establish coverage. The policy treats FDA information as informational; coverage requires that the service or product meet the policy’s medical necessity criteria and the member specific benefit plan.

Applicable Billing Codes and Coding Guidance

Applicable HCPCS and S codesHCPCS

B4100	Food thickener; administered orally, per 0Z.
B4102	Enteral formula, for adults, used to replace fluids and electrolytes (e.g., clear liquids), 500 ml = 1 unit.
B4103	Enteral formula, for pediatrics, used to replace fluids and electrolytes (clear liquids), 500 ml = 1 unit.
B4104	Additive for enteral formula (e.g., fiber).
B4149	Enteral formula, manufactured blenderized natural foods with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit.
B4150	Enteral formula, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit.
B4152	Enteral formula, nutritionally complete, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit.
B4153	Enteral formula, nutritionally complete, hydrolyzed proteins (amino acids and peptide chain); includes fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit.
B4155	Enteral formula, nutritionally incomplete/modular nutrients, includes specific nutrients, carbohydrates (e.g., glucose polymers), proteins/amino acids (e.g., glutamine, arginine), fat (e.g., medium chain triglycerides) or combination, administered through an enteral feeding tube, 100 calories = 1 unit.
B4157	Enteral formula for special metabolic needs, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit.

1–10 of 19

1/2

Applicable S codes (HCPCS S-series)HCPCS

S9432	Medical foods for noninborn errors of metabolism
S9433	Medical food nutritionally complete, administered orally, providing 100% of nutritional intake.
S9434	Modified solid food supplements for inborn errors of metabolism.
S9435	Medical foods for inborn errors of metabolism.

Phenylalanine target (PKU monitoring)

Phenylalanine targetTarget plasma phenylalanine (Phe) level < 360 umol/L (goal associated with reduced risk to offspring and better outcomes)

Evidence basisAchieving Phe < 360 umol/L shown to substantially lower risk of adverse outcomes in pregnancy (Adams et al., systematic review)

Methods to achieve targetDietary restriction and/or pharmacologic Phe‑lowering agents may be used to reach < 360 umol/L

Malnutrition and nutrition support thresholds (examples)

Adult malnutrition diagnosisDiagnosis supported when TWO OR MORE of: unintentional weight loss; insufficient energy intake; loss of muscle mass; loss of subcutaneous fat; diminished functional status; or fluid accumulation.

Pediatric z‑score thresholds

Provider Actions, Prior Authorization, and Step Therapy

Prior Authorization

InterQual-based prior authorization

Enteral tube feeding determinations follow InterQual CP: Durable Medical Equipment; Enteral and Parenteral Nutrition Therapy and prior authorization may be required per the member’s benefit and plan rules for the listed HCPCS/S codes.

InterQual criteria determine medical necessity for tube-enteral nutrition; submit InterQual documentation when requesting tube feeding authorization.
Include applicable HCPCS/S codes from the policy when requesting authorization (see code list such as B4150, B4153, B4162, S9433).

Prior Authorization

Prior authorization for specialized enteral formulas — evidence support required

Requests for specialized enteral formulas (including elemental or metabolic formulas) must be supported by clinical evidence of the indication and prior intolerance or failure of less-restrictive dietary measures when applicable (for example, evidence supporting induction/maintenance in Crohn’s disease or failure of extensively hydrolyzed formulas in severe food allergies/EoE).

Document guideline- or trial-based rationale (e.g., CDED plus partial enteral nutrition data, RCT evidence, or high efficacy of amino acid-based formulas in EoE).

Medical Necessity Criteria and DME Rules

DME-related medical necessity (top-level node)

DME medical necessity: Tube feeding per InterQual OR oral Medical Foods when oral criteria are all met

InterQual criteria apply for tube feeding; five specified requirements apply for oral medical foods.

DME medical necessity — enteral feeding supplies and equipment medically necessary when:

Enteral feeding supplies and equipment are medically necessary when:

Pediatric CKD and growth failure: Child with CKD (stages 2–5) or on dialysis with inadequate oral intake to meet energy/protein needs despite dietary counseling, necessitating supplemental enteral feeding.

Follow KDOQI/PRNT and AAP nutritional prescriptions and monitoring.

Severe allergy or EoE:

Rental, Purchase, and Administrative Procurement Rules

Equipment / Topic	Policy Statement
Enteral feeding equipment rental/purchase rules	No equipment-specific rental or purchase rules are specified in this policy segment.
Replacement intervals	No replacement intervals for enteral equipment are specified in this document segment.

Administrative Action	Guidance
Verify member-specific benefit plan	Check the member specific benefit plan document and any applicable federal or state mandates before applying this policy; the member specific benefit plan governs in the event of a conflict.
Authorization and procurement rules	Prior authorization requirements and procurement processes may vary by plan; UnitedHealthcare may use third‑party tools (for example, InterQual) to assist with administration and may require review against this policy.

Replacement and Durable Medical Equipment Replacement Guidance

Replacement rules

Replacement intervals specifiedNo replacement intervals for enteral equipment or explicit replacement rules are specified in this policy segment.

Action when replacement neededFollow member‑specific benefit plan and supplier/vendor administrative rules for procurement and replacement, as policy provides no equipment‑specific guidance.

Documentation for replacementIf replacement is requested, document medical necessity, device failure or clinical justification per the member plan and InterQual criteria for tube feeding.

Replacement administrative note

Verify member plan before replacementCheck the member specific benefit plan and any applicable federal/state mandates for authorization and replacement procurement rules prior to approving replacement.

Administrative review

Required Documentation to Support Medical Necessity

Documentation Required

Clinical notes and prescriptions supporting chronic condition and tube feeding necessity

Include clinical notes and a prescriber order documenting the chronic condition, failure of dietary measures (when applicable), and that oral intake is inadequate to meet nutritional needs; for tube feeding, include InterQual documentation used to justify the necessity of enteral tube feeding.

Attach the prescriber’s signed order specifying enteral tube feeding or medical food and rationale for tube versus oral route.
Include the InterQual output or criteria references relied upon to determine tube feeding necessity.

Documentation Required

Clinical assessments and nutrition monitoring records to justify enteral formula and device use

Provide clinical assessments and nutrition monitoring records to justify enteral formula and device use, including anthropometrics, standardized malnutrition assessments (z‑scores, BMI‑for‑age), nutrient intake records, and laboratory indexes of metabolic control and nutrition adequacy.

Supply weight/height trends, z‑scores, and intake documentation showing insufficiency of oral diet.

Items and Services Not Covered

Common exclusions that are not covered include: commercial food thickeners, donor breast milk, and routine standard infant or milk‑based formulas provided for oral intake. Additionally, self‑blenderized formulas for oral intake and oral electrolyte or additive products used to replace fluids or electrolytes are excluded. High‑dose or mega‑dose vitamin/mineral therapies and similar nutrition‑based cosmetic therapies are also listed as exclusions.

Relaxation of restrictive metabolic diets (for example, easing PKU phenylalanine limits) without specialist evaluation and objective monitoring is not covered. The literature does not provide clear, evidence‑based thresholds for when to relax diets, and trials show individual variability in biochemical response to altered protein substitute dosing; therefore changes in therapy require metabolic specialist oversight and serial biochemical monitoring to support coverage.

The policy does not base coverage solely on device or product regulatory status. There are no device exclusions listed that would make FDA clearance or approval the sole determinant of coverage. Instead, coverage decisions require satisfaction of the medical necessity criteria in this policy and verification against the member specific benefit plan and any applicable mandates.

Background and Scope

Background: Enteral nutrition provides nutrients via the gastrointestinal tract and can be delivered orally or by tube (eg, nasogastric, gastrostomy, jejunostomy). Products range from standard oral or tube formulas to Specialized Nutrient Formulas (medical foods) intended for disease‑specific nutritional management and elemental (amino acid–based) formulas for severe allergies or malabsorption. Tube feeding medical necessity is determined using InterQual criteria, while oral medical foods require documentation that the condition is chronic, prescribed by an appropriate clinician, and cannot be managed by ordinary dietary adjustment.

Definitions

Inborn Errors of Metabolism — definition and examples

DefinitionInborn Errors of Metabolism are disorders that cause a block in a metabolic pathway leading to clinically significant consequences.

ExamplesExamples include phenylketonuria (PKU), maple syrup urine disease, homocystinuria, methylmalonic acidemia, propionic acidemia, isovaleric acidemia, glutaric aciduria, tyrosinemia, and urea cycle disorders.

Clinical implicationThese conditions often require specialized dietary management or medical foods to address distinctive nutrient requirements.

Medical Food / Medical Foods — definition

Regulatory definitionMedical Food: a food formulated to be consumed or administered enterally under physician supervision for the dietary management of a disease or condition with distinctive nutritional requirements (21 CFR and Orphan Drug Act definitions).

Key characteristics

Policy Revision History

2025-06-01policy_revisionLatest

Revised Oral Nutrition coverage rationale to expand qualifying conditions for Specialized Nutrient Formula to explicitly include FPIAP and FPIES, and clarified 'gastroesophageal reflux with failure to thrive' as 'gastroesophageal reflux with failure to thrive (in children)'; updated the definition of 'Medical Food' and refreshed Clinical Evidence and References.

Policy Summary

PayerUnitedHealthcare

PolicyEnteral Nutrition (Oral and Tube Feeding)

Policy CodePolicy MP.027.12

Change TypeCoverage criteria revised — expanded qualifying conditions for oral Specialized Nutrient Formula

Effective DateJun 1, 2025

Next Review DateN/A

SourceLink

On This Page

Randomized trial data (Levine et al.) support CDED plus partial enteral nutrition.

Severe food allergies and eosinophilic esophagitis: Amino acid–based elemental formulas are indicated for severe non–IgE-mediated food allergies (e.g., FPIES, FPIAP) and for severe eosinophilic esophagitis, especially when extensively hydrolyzed formulas fail or when faltering growth is present; elemental formulas demonstrate high efficacy for inducing remission in EoE.

Meta-analysis shows ~90.8% efficacy for elemental formulas in EoE.

Cystic fibrosis with malabsorption and growth deficits: Oral and enteral nutritional supplements (including tube feeding) are recommended to improve weight gain and growth in patients with cystic fibrosis and growth/weight deficits; follow pancreatic enzyme replacement and CF Foundation guidance.

CF Foundation recommendations cited.

Malnutrition in critical illness (pediatrics): Enteral nutrition with higher-protein formulations may be indicated in critically ill children to address increased protein needs and support recovery when oral intake is insufficient; monitor tolerance and biochemical markers.

Small RCTs show biochemical benefit for protein-enriched enteral diets.

z-score thresholds per Academy/ASPEN

Becker et al., 2015 guidance.

NICE criteria for nutrition support: Consider nutrition support when BMI <18.5; or BMI <20 with unintentional weight loss >5% in 3–6 months; or unintentional weight loss >10% in 3–6 months; poor absorptive capacity/high nutrient losses/increased needs; or minimal intake >5 days.BMI and weight loss thresholds

NICE guidance.

GERD in infants recommendation: For infants with gastroesophageal reflux and failure to thrive, consider a 2–4 week trial of extensively hydrolyzed protein formula or an amino-acid based formula after optimal non-pharmacologic treatment has failed.2–4 week trial

NASPGHAN/ESPGHAN guidance.

Specialized nutrient formula coverage revision: Coverage criteria for specialized oral nutrient formulas were revised to explicitly include severe food allergies (including eosinophilic esophagitis), other eosinophilic GI diseases, FPIAP, and FPIES when, if untreated, these conditions would cause life-threatening allergic reactions, malnourishment, or death.clinical severity causing risk of malnutrition or life-threatening reaction

Policy change effective 06/01/2025.

Severity defined by z‑scores (examples): severe ≤ -3 z; moderate and mild defined per Academy/ASPEN weight‑for‑height and BMI‑for‑age cutoffs.

NICE adult thresholds for nutrition supportConsider nutrition support when BMI <18.5 kg/m2, or BMI <20 kg/m2 with unintentional weight loss >5% in 3–6 months, or unintentional weight loss >10% in 3–6 months.

Weight gain velocity (infants)<2 yrsMild/moderate/severe defined by percent of expected weight gain: mild <75% norm, moderate <50%, severe <25% of expected velocity.

Show prior trials of alternative diets or formulas unless clinical severity (e.g., failure to thrive) justifies immediate elemental formula use.

Prior Authorization

Prior authorization: verify member plan and mandates

Verify the member-specific benefit plan and any applicable state or federal mandates before submitting an authorization; the member-specific plan governs in case of conflict and UnitedHealthcare may require policy review or use third‑party tools.

Cite the member-specific benefit document and any mandates in the authorization request.
Expect UnitedHealthcare to reference InterQual or other tools as part of review per policy instructions.

Step Therapy

InterQual step guidance

Use InterQual criteria to guide stepwise medical necessity determinations for tube-enteral nutrition; InterQual is the referenced clinical coverage pathway for DME enteral and parenteral nutrition therapy.

When tube feeding is proposed, include InterQual-based clinical triggers and documentation used to justify necessity.
InterQual guidance should be part of the authorization and medical record evidence package.

Step Therapy

Step approach for enteral formula selection

Apply a step approach for formula selection: trial standard dietary interventions or partial enteral nutrition approaches (e.g., CDED plus partial enteral nutrition) before escalating to exclusive elemental/amino-acid formulas except in severe cases (failure to thrive, severe complex allergies) where immediate elemental formulas may be indicated.

Document trials of less-restrictive diets or partial enteral nutrition and their outcomes when available.
If immediate elemental formula is required due to severity, document the clinical justification (e.g., faltering growth, severe allergy).

Step Therapy

Trial of hydrolyzed/amino‑acid formula (2–4 week trial guidance)

For infants with suspected GERD and failure to thrive, document a 2–4 week trial of an extensively hydrolyzed or amino‑acid–based formula after non‑pharmacologic measures have failed, per NASPGHAN/ESPGHAN guidance.

Record start and stop dates and clinical response for the 2–4 week trial.
If trial fails or severe symptoms are present, document rationale for switching to amino‑acid formula.

Documentation Required

Required clinical documentation — prescriber and order

Obtain and include a prescription or order from a physician, advanced practitioner (NP, CNS, or PA), or registered dietician; document that the condition is chronic and that adequate nutrition cannot be achieved by dietary adjustment.

Include the signed prescriber order specifying the product, dose, route (oral or tube), and duration.
State the chronicity of the condition and prior conservative management attempts in the clinical notes.

Documentation Required

Required clinical documentation — nutrition status and monitoring

Document objective assessments of nutrition status and monitoring: anthropometrics, standardized malnutrition indicators (z-scores, BMI-for-age), nutrient intake records, clinical signs/symptoms, and relevant laboratory indexes of metabolic control and nutrition adequacy.

Include weight/height, weight‑for‑height or BMI z‑scores, trend data, and evidence of inadequate oral intake.
Attach lab results and notes on vitamin/mineral supplementation when medical foods lack complete micronutrients.

Documentation Required

Medical food and member‑plan documentation requirements

When requesting coverage for medical foods, document that the product is formulated for enteral administration under physician supervision and that the patient has distinctive nutritional requirements not manageable by normal diet; cite the member‑specific benefit plan and any applicable mandates.

Provide the physician supervision statement and the medical food labeling/indication supporting distinctive nutritional requirements.
Reference the member-specific plan language and any applicable state or federal mandates in the request.

Denial Risk

Coverage-based denial risk when oral criteria not met

Billing standard oral formulas or specialized formulas without meeting the policy’s Oral Nutrition criteria risks claim denial; standard oral formulas and specialized formulas that do not meet the Coverage Rationale are generally not covered.

Ensure all five Oral Specialized Nutrient Formula criteria are documented before billing oral medical foods.
Do not bill medical-food HCPCS/S codes when oral criteria are not met to avoid denial.

Denial Risk

Documentation of monitoring for metabolic disorders — denial risk if absent

If documentation of nutrition monitoring (anthropometrics, clinical signs/symptoms, nutrient intake, laboratory indexes) is absent, coverage for medical foods or specialized formulas may be denied for lack of medical necessity.

Include recent anthropometric measures, intake records, and lab indexes in the chart when requesting medical foods.
Document ongoing monitoring plans if long-term medical food therapy is requested.

Denial Risk

Denial risk when criteria not met (policy revisions noted)

Services that do not meet the updated coverage rationale (including the revised list of qualifying conditions for oral Specialized Nutrient Formula effective 06/01/2025) are at risk for denial under the revised policy.

Confirm the patient’s condition is among the expanded qualifying conditions (e.g., severe food allergies, EoE, FPIAP, FPIES) and document clinical severity.
Reference the policy effective date and ensure authorization requests adhere to the revised criteria.

Patient with severe food allergy or eosinophilic esophagitis who has failed extensively hydrolyzed formulas or has faltering growth requiring elemental (amino acid–based) formula delivered enterally.

Indication supported by allergy and gastroenterology guidance and evidence for elemental formula efficacy.

Critical illness with malnutrition: Critically ill pediatric patient requiring enteral nutrition to meet protein/energy goals when oral intake is insufficient and enteral delivery is necessary to support recovery.

RCT data support higher-protein enteral formulas in critically ill children for biochemical markers of recovery.

DME medical necessity criteria (guideline‑based)

Clinical criteria supporting medical necessity for enteral nutrition and medical foods are guided by professional society recommendations:

Medical supervision and distinctive requirements: Medical foods must be administered enterally under physician supervision for conditions with distinctive nutritional requirements established by medical evaluation.

Definition and supervision requirement referenced in policy definitions and FDA informational section.

Indications for oral or enteral nutrition support: Indications include diagnosed malnutrition per Academy/ASPEN (2+ characteristics), pediatric malnutrition per z-score thresholds, NICE thresholds for adults at risk, and disease states causing poor intake or absorption that meet guideline thresholds.See guideline thresholds

ESPEN and ASPEN guidance support use of oral supplements or home enteral nutrition in at‑risk patients.

UnitedHealthcare may require review against this policy and use third‑party tools (eg, InterQual) to verify medical necessity and replacement eligibility.

RecordkeepingRetain physician order and documentation of clinical need and any vendor/supplier replacement reports to support authorization per plan rules.

Include lab data and notes documenting need for specialized formula or supplementation.

Billing Rule

Physician order/medical necessity documentation and plan verification

Ensure a physician order or other authorized prescriber documentation of medical necessity is in the record and include verification of the member‑specific benefit plan when requesting coverage for medical foods or enteral nutrition.

Attach the physician/advanced practitioner/dietitian order and explicit medical necessity statement.
Cite the member-specific benefit plan language and any applicable mandates within the authorization packet.

Intended for patients with limited capacity to ingest/digest/absorb/metabolize ordinary foodstuffs; specially formulated and processed for oral or enteral feeding; used under ongoing medical supervision.

Place of useTypically obtained through hospitals, clinics, and long‑term care facilities and labeled for use under medical supervision.

Specialized Nutrient Formula — definition

DefinitionSpecialized Nutrient Formula: a formula produced to meet unique nutrient needs for specific disease conditions, formulated for oral or enteral feeding.

Use caseProduced to address distinctive nutritional requirements that cannot be met by modification of a normal diet alone.

Relation to medical foodsSpecialized nutrient formulas are a subset of enteral nutrition products that may qualify as Medical Foods when used under medical supervision.

GMP‑MFs (glycomacropeptide medical foods) — note

What they areGMP‑MFs (glycomacropeptide medical foods) are low‑phenylalanine medical foods derived from glycomacropeptide used as an alternative to traditional amino acid‑based medical foods in PKU management.

Tolerability and adherenceClinical trials reported greater acceptability, improved GI symptoms, and higher frequency of intake with GMP‑MFs versus AA‑MFs, which may enhance dietary adherence.

Efficacy noteShort crossover trials (3‑week treatment periods) showed GMP‑MFs are a safe and acceptable option; plasma Phe changes varied across studies.

Elemental (amino acid-based) formula — definition and efficacy note

DefinitionElemental (amino acid‑based) formula: a formula composed of free amino acids used for severe food allergies and eosinophilic esophagitis.

Efficacy in EoEMeta‑analysis evidence demonstrates amino acid‑based elemental formulas achieved remission in approximately 90.8% of EoE cases.

IndicationsRecommended for infants and children with faltering growth, symptoms unresponsive to extensively hydrolyzed formulas, multiple food eliminations, or severe complex GI food allergies.

Medical Food — alternate definition

Regulatory/definition statementA Medical Food is formulated to be consumed or administered enterally under physician supervision for the dietary management of a disease or condition with distinctive nutritional requirements; it is intended for use under medical supervision and provides nutritional support modified for the specific disease.

Distinguishing featuresMedical Foods are specially formulated and processed (not naturally occurring in unmodified form) and are intended for partial or exclusive feeding by mouth or tube.

Documentation expectationUse of Medical Foods requires physician supervision and documentation that dietary management cannot be achieved with normal diet modification alone.

Malnutrition indicators (Academy/ASPEN) — definitions

Adult malnutrition indicatorsDiagnosis recommended when TWO OR MORE of: weight loss; insufficient energy intake; loss of muscle mass; loss of subcutaneous fat; diminished functional status (eg, hand grip strength); or fluid accumulation.

Pediatric primary indicatorsUse standardized measures: weight‑for‑height, BMI‑for‑age, length/height‑for‑age, circumference z‑scores, and weight gain velocity; severity defined by z‑score cutoffs (eg, severe ≤ -3 z).

Weight gain velocity and weight loss thresholdsWeight gain velocity in <2 years: mild <75% of expected, moderate <50%, severe <25%; weight loss (2–20 years) mild = 5% usual body weight, moderate = 7.5%, severe = 10%.